CGM Academy for Youth With Type 1 Diabetes
Launched by CHILDREN'S HOSPITAL LOS ANGELES · May 8, 2024
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the CGM Academy for Youth with Type 1 Diabetes, is studying how a special online education program can help young people manage their blood sugar levels better than standard education. The trial involves two groups of participants: one group will use an interactive workbook and attend online sessions with diabetes experts, while the other group will receive the usual education about diabetes. Researchers want to find out if the new program leads to better blood sugar control and how it affects feelings about diabetes and family responsibilities.
To participate, you need to be between 8 and 18 years old and have had type 1 diabetes for at least six months. Participants must also have the Dexcom G6 or G7 continuous glucose monitoring system and be comfortable with virtual meetings. Throughout the study, everyone will fill out some questionnaires to help the researchers gather important information. If you or someone you know fits these criteria and is interested, this could be a great opportunity to learn more about managing type 1 diabetes effectively.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Current age of 8-18 years, age group eligible for CGM therapy with Dexcom G6 and G7
- • T1D duration ≥6 months, as insulin adjustments during honeymoon stage differs from establishedT1D
- • Able to speak, read, and write English or Spanish
- • Smartphone compatible with Dexcom G6 and G7application
- • Ability to participate in virtual visits
- Exclusion Criteria:
- • • Known history of medical adhesive allergies
About Children's Hospital Los Angeles
Children's Hospital Los Angeles (CHLA) is a renowned pediatric healthcare institution dedicated to advancing the health and well-being of children through innovative research and clinical care. As a leading clinical trial sponsor, CHLA is committed to conducting high-quality, ethical research that addresses critical pediatric health issues. With a focus on translating scientific discoveries into effective treatments, CHLA collaborates with multidisciplinary teams and leverages state-of-the-art facilities to support a wide range of clinical trials. Their mission is to enhance the understanding and treatment of childhood diseases, ultimately improving outcomes for young patients and their families.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Patients applied
Trial Officials
Rebecca Barber, PhD, RN
Principal Investigator
Children's Hospital Los Angeles
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported